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Abstract
Background: Lipoprotein ratios have been shown to be associated with the occurrence of coronary heart disease
(CHD), but little is known about their relationships with the severity of CHD.
Methods: A total of 792 angiographically defined CHD patients were enrolled following their admission. Patients
were stratified into three groups based on the tertile of the Gensini scores (≤33rd percentile, 33rd to 66th percentile
and ≥66th percentile) or the number of stenotic coronary branches (single-branch stenosis, double-branch stenosis
and multi-branch stenosis). Demographic and biochemical data were collected and lipoprotein ratios were
calculated. Logistic regression and path analysis were employed to examine the relationships between the
lipoprotein ratios and the severity of CHD.
Results: The ratios of low-density lipoprotein cholesterol (LDL-C)/high-density lipoprotein cholesterol (HDL-C) and
apolipoprotein B100 (apoB100)/apolipoprotein AI (apoAI) increased with the tertile of the Gensini scores (P < 0.05
for both). The ratios of triglyceride (TG)/HDL-C, total cholesterol (TC)/HDL-C, LDL-C/HDL-C and apoB100/apoAI
increased with the number of stenotic coronary branches (P < 0.05 for all). The univariate logistic regression showed
that the ratios of TC/HDL-C, LDL-C/HDL-C and apoB100/apoAI were positively associated with both the tertile of
the Gensini scores and the number of stenotic vessels (P < 0.05 for all), and the ratio of TG/HDL-C was positively
associated with the number of stenotic vessels (P < 0.05). In multivariate logistic analysis, only the ratio of apoB100/
apoAI was independently and positively associated with the tertile of the Gensini scores (OR = 2.93, 95 % CI =
1.17-7.34, P = 0.022) and the number of stenotic vessels (OR = 3.14, 95 % CI = 1.01-6.47, P = 0.048) after adjusting for
the possible confounding variables. The apoB100/apoAI ratio was also shown to be a direct mediator between the
risk factors including age, BMI, HDL-C, LDL-C, apoB100 and apoAI and the severity of CHD by path analysis.
Conclusion: Our data indicate that the apoB100/apoAI ratio could be a useful predictor for evaluating the severity
of coronary stenosis in CHD patients.
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Background
Coronary heart disease (CHD) is the major cause of
death in developed countries and some developing
countries like China [1]. CHD is recognized as a
multifactorial disease, and dyslipidemia is closely asso-
ciated with the progression of coronary atheroscler-
osis. Yusuf S and colleagues [2] demonstrated that
dyslipidemia could account for around 50 % of the
population-attributable risk for CHD. Reliable indexes
for assessing the CHD risk and the extent of coronary
stenosis are pivotal to manage and prevent this crit-
ical disease. The roles of plasma low-density lipopro-
tein cholesterol (LDL-C), total cholesterol (TC), high-
density lipoprotein cholesterol (HDL-C) and triglycer-
ides (TG) in the development of CHD have been well
established. Currently, increases in LDL-C, TC, TG
and/or decreases in HDL-C are widely used to evalu-
ate the risk of CHD in clinical practice. According to
the 2013 ACC/AHA blood cholesterol guidelines [3]
and the Adult Treatment Panel III (ATP III) Guide-
lines [4] of the United States, LDL-C is considered as
the major cause of CHD and used as the primary tar-
get for therapy, and the other lipid parameters were
used as the secondary or supplementary targets.
Although there were growing arguments that the
lipoprotein ratios, which have atherogenic compo-
nents (TG, TC and LDL-C) in the numerator and
antiatherogenic components (HDL-C) in the denom-
inator, could be better predictors for the occurrence
[5–7] and development of CHD [8–12] than the indi-
vidual lipid parameters, the roles of the lipoprotein
ratios in the pathogenesis of CHD are still obscure.
One point to support these arguments is that the
lipoprotein ratios can comprehensively reflect the bal-
ance between the atherogenic and antiatherogenic po-
tentials in one individual. An increase in TG, TC or
LDL-C concentrations is an atherogenic lipid marker,
whereas reduced HDL-C concentration is an anti-
atherogenic trait which may also be correlated with
numerous other cardiovascular risk factors, including
the components of the metabolic syndrome. In an
angiography-based study, Lippi U et al. [8] were the
first to report that TC/HDL-C and LDL-C/HDL-C are
statistically related to the severity of CHD. Their find-
ings were later proved by another study [9] from
Zhejiang University, China, in which the researchers
demonstrated that the ratios of LDL-C/HDL-C and
TC/HDL-C were significantly and positively correlated
with the coronary artery lesions. A recent cross-
sectional association study [10] in a Lebanese popula-
tion further revealed that the TC/HDL-C ratio ≥4
significantly predicts ≥50 % stenosis in all vessels.
The ratio of TG/HDL-C was also found to be associ-
ated with the severity of CHD in two studies from
Ruijin Hospital, Shanghai Jiaotong University, China
[11] and Insituto do Coração, Universidade de São
Paulo, Brazil [12], respectively.
However, none of these studies on outcomes have
evaluated the association of the apolipoprotein B100
(apoB100)/apolipoprotein AI (apoAI) ratio with the se-
verity of CHD. In theory, the apoB100/apoAI ratio
should be an even better predictor for evaluating the se-
verity of CHD than the HDL-C related ratios. Each par-
ticle of the atherogenic lipoproteins [low-density
lipoprotein, very low-density lipoprotein, intermediary
density lipoprotein and lipoprotein (a)] carries one
apoB100 molecule, so the concentrations of plasma
apoB100 can reflect the total number of atherogenic par-
ticles. On the other hand, apoAI accounts for about
70 % of the total apolipoproteins in high-density lipopro-
tein; the plasma content of apoAI represents the total of
antiatherogenic particles. Therefore, the apoB100/apoAI
ratio might be a superior marker for CHD development
in that it can comprehensively reflect the balance be-
tween the atherogenic particles and antiatherogenic par-
ticles. Several studies [13–16] have suggested that the
apoB100/apoAI ratio is better than the HDL-C related
ratios in predicting the occurrence of CHD. In a pro-
spective apolipoprotein-related mortality risk (AMORIS)
study [13], the researchers reported that the apoB100/
apoAI ratio was strongly related to increased coronary
risk, and was superior to any of the HDL-C related ra-
tios in predicting CHD in a large sample of 69,030 men
and 57,168 women above 40 years of age. Liem AH et al.
[14] demonstrated that the apoB100/apoAI, but not the
LDL-C/HDL-C ratio, is positively associated with cardio-
vascular events in statin-treated patients with known CHD.
We previously demonstrated that the lipoprotein ratios
are superior to the individual lipid parameters as predic-
tors for CHD occurrence, and the apoB100/apoAI ratio
is the best one to predict CHD [7]. In the current study,
we further investigated the associations between the ra-
tios of TG/HDL-C, TC/HDL-C, LDL-C/HDL-C and
apoB100/apoAI and the severity of CHD. We hypothe-
sized that higher levels of TG/HDL-C, TC/HDL-C,
LDL-C/HDL-C, and especially apoB100/apoAI are asso-
ciated with more severe CHD.
Results
Clinical characteristics of the study population
The CHD patients were divided into three groups ac-
cording to the tertile of the Gensini scores: group 1: ≤
33rd percentile (scores ≤ 11.5); group 2: 33rd to 66th per-
centile (scores 12–32); group 3: ≥66th percentile
(scores ≥ 33). The anthropometric and biochemical char-
acteristics of the three groups are shown in Table 1. The
mean age, and the prevalence of male gender and smok-
ing increased with the tertile of the Gensini scores (P <
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0.05 for all). The ratios of LDL-C/HDL-C and apoB/
apoAI increased, whereas HDL-C and apoAI decreased
with the tertile of the Gensini scores (P < 0.05 for all).
There were no significant differences in weight, BMI,
prevalence of hypertension and diabetes, TG, TC, LDL-
C, apoB100, TG/HDL-C and TC/HDL-C across the
groups.
The anthropometric and biochemical characteristics of
the CHD patients with different number of stenotic ves-
sels are shown in Table 2. The mean age, and the preva-
lence of male gender, cigarette smoking, hypertension
and diabetes increased with the number of stenotic ves-
sels (P < 0.05 for all). TG, TC, LDL-C, apoB100, the ra-
tios of TG/HDL-C, TC/HDL-C, LDL-C/HDL-C and
apoB/apoAI increased, and HDL-C and apoAI decreased
with the number of stenotic vessels (P < 0.05 for all).
There were no significant differences in weight and BMI
across the groups.
Univariate logistic regression of the lipoprotein ratios and
the severity of CHD
Univariate logistic regression analyses showed that the
ratio of TG/HDL-C was significantly associated with the
number of stenotic vessels (P < 0.05), but not with the
tertile of the Gensini scores. The ratios of TC/HDL-C,
LDL-C/HDL-C and apoB100/apoAI were significantly
associated with both the tertile of the Gensini scores and
the number of stenotic vessels (P < 0.05 for all)
(Table 3).
Multivariate logistic regression of the lipoprotein ratios
and the severity of CHD
As shown in Table 4, the ratios of TC/HDL-C and LDL-
C/HDL-C were significantly associated with both the
tertile of the Gensini scores and the number of stenotic
vessels, and TG/HDL-C was significantly associated with
the number of stenotic vessels after adjusting for the
non-lipid cardiovascular risk factors including age, gen-
der, weight, BMI, smoking, alcohol consumption, dia-
betes mellitus and hypertension (model 1). However, all
the associations between the ratios of TG/HDL-C, TC/
HDL-C and LDL-C/HDL-C and the severity of CHD be-
came insignificant after adjusting for the variables in
model 1 plus the individual lipid variables including TG,
HDL-C, LDL-C, apoB100 and apoAI. TC was excluded
during the model-building process due to its significant
Table 1 Clinical characteristics of the CHD patients according to the tertile of the Gensini scores
Variables Group 1 Group 2 Group 3 P value
≤33rd percentile (n = 265) 33rd to 66th percentile (n = 261) ≥66th percentile (n = 266)
Non-lipid variables
Age, years 62.06 ± 9.98 62.68 ± 10.61 64.95 ± 9.67 0.003
Male gender, n (%) 171 (64.5) 172 (65.9) 204 (76.7) 0.004
Weight, kg 64.95 ± 9.29 63.39 ± 9.36 64.67 ± 9.63 0.225
BMI, kg/m2 24.56 ± 2.84 24.15 ± 3.03 24.16 ± 3.04 0.399
Smokers, n (%) 95 (35.8) 120 (46.0) 133 (50.0) 0.003
Hypertension, n (%) 119 (44.9) 141 (54.0) 138 (51.9) 0.091
Diabetes, n (%) 35 (13.2) 34 (13.0) 51 (19.2) 0.080
Individual lipid variables
TG, mmol/L 1.53 ± 0.90 1.49 ± 1.09 1.66 ± 1.14 0.156
TC, mmol/L 4.16 ± 0.94 4.22 ± 1.01 4.23 ± 1.20 0.728
HDL-C, mmol/L 1.01 ± 0.29 1.02 ± 0.34 0.93 ± 0.29 0.001
LDL-C, mmol/L 2.37 ± 0.75 2.44 ± 0.81 2.49 ± 0.94 0.263
ApoAI, g/L 1.03 ± 0.19 1.02 ± 0.21 0.95 ± 0.21 <0.001
ApoB100, g/L 0.76 ± 0.24 0.77 ± 0.25 0.80 ± 0.28 0.204
Lipoprotein ratios
TG/HDL-C 1.83 ± 2.06 2.09 ± 4.41 2.16 ± 2.53 0.466
TC/HDL-C 4.51 ± 1.92 4.73 ± 3.58 5.03 ± 3.18 0.079
LDL-C/HDL-C 2.57 ± 1.11 2.70 ± 1.75 2.96 ± 2.01 0.024
ApoB/apoAI 0.76 ± 0.27 0.78 ± 0.29 0.88 ± 0.43 <0.001
The differences across the tertile of the Gensini scores were calculated by Chi-square test for categorical variables, and one-way ANOVA analysis for
continuous variables
BMI body mass index, TG triglycerides, TC total cholesterol, HDL-C high-density lipoprotein cholesterol, LDL-C low-density lipoprotein cholesterol, apoAI apolipopro-
tein AI, apoB100 apolipoprotein B100
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collinearity with LDL-C. ApoB100/apoAI was independ-
ently and significantly associated with the tertile of the
Gensini scores and the number of stenotic vessels after
adjusting for the variables in model 2 plus the lipopro-
tein ratios including TG/HDL-C and LDL-C/HDL-C
(Table 4). TC/HDL-C was excluded from the model as it
is highly correlated with LDL-C/HDL-C.
Path analysis of the lipoprotein ratios and the severity of
CHD
Path analysis indicated that age, smoking, diabetes, TG,
LDL-C, apoAI and apoB100/apoAI had direct effects on
the severity of CHD. Among them, age, smoking, apoAI
and apoB100/apoAI had direct effect on the tertile of
the Gensini scores (Fig. 1), and age, diabetes, TG, LDL-
C, apoAI and apoB100/apoAI had direct effect on the
number of stenotic branches (Fig. 2). The variables in-
cluding age, male gender, BMI, HDL-C, LDL-C, apoB100
and apoAI also had indirect effects on the severity of
CHD mediated by the apoB100/apoAI ratio. There were
11 paths (age→ apoB100/apoAI→ the tertile of the
Gensini scores or the number of stenotic vessels, BMI→
apoB100/apoAI→ the tertile of the Gensini scores or
the number of stenotic vessels, HDL-C→ apoB100/
Table 2 Clinical characteristics of the CHD patients with different number of stenotic vessels
Variables Single-branch stenosis (n = 327) Double-branch stenosis (n = 212) Multi-branch stenosis (n = 253) P value
Non-lipid variables
Age, years 61.93 ± 10.25 63.04 ± 9.56 65.12 ± 10.25 0.001
Male gender, n (%) 197 (60.2) 158 (74.5) 193 (76.3) <0.001
Weight, kg 64.26 ± 9.62 64.32 ± 8.71 64.43 ± 9.81 0.985
BMI, kg/m2 24.43 ± 2.80 24.40 ± 3.15 24.31 ± 3.13 0.923
Smokers, n (%) 119 (36.4) 103 (48.6) 123 (48.6) 0.003
Hypertension, n (%) 155 (47.4) 97 (45.8) 142 (56.1) 0.045
Diabetes, n (%) 37 (11.3) 32 (15.1) 51 (20.2) 0.013
Individual lipid variables
TG, mmol/L 1.44 ± 0.80 1.63 ± 1.08 1.67 ± 1.30 0.049
TC, mmol/L 4.07 ± 0.87 4.32 ± 1.10 4.30 ± 1.22 0.028
HDL-C, mmol/L 1.03 ± 0.308 0.99 ± 0.33 0.94 ± 0.30 0.003
LDL-C, mmol/L 2.31 ± 0.73 2.50 ± 0.83 2.56 ± 0.97 0.004
ApoAI, g/L 1.03 ± 0.20 1.00 ± 0.20 0.96 ± 0.22 0.001
ApoB100, g/L 0.74 ± 0.24 0.79 ± 0.25 0.80 ± 0.29 0.009
Lipoprotein ratios
TG/HDL-C 1.64 ± 1.36 2.20 ± 2.70 2.43 ± 5.05 0.003
TC/HDL-C 4.26 ± 1.50 5.10 ± 4.01 5.12 ± 3.33 <0.001
LDL-C/HDL-C 2.44 ± 1.03 2.87 ± 1.83 3.05 ± 3.05 <0.001
ApoB/apoAI 0.74 ± 0.26 0.81 ± 0.28 0.88 ± 0.45 <0.001
The differences across the groups with different number of stenotic vessels were calculated by Chi-square test for categorical variables, and one-way ANOVA
analysis for continuous variables
BMI body mass index, TG triglycerides, TC total cholesterol, HDL-C high-density lipoprotein cholesterol, LDL-C low-density lipoprotein cholesterol, apoAI
apolipoprotein AI, apoB100 apolipoprotein B100
Table 3 Results of the univariate ordinal logistic regression of the lipoprotein ratios and the tertile of the Gensini scores or the
number of stenotic vessels
Variables The tertile of the Gensini scores The number of stenotic vessels
OR 95 % CI P OR 95 % CI P
TG/HDL-C 1.02 0.98–1.07 0.341 1.05 1.01–1.09 0.021
TC/HDL-C 1.05 1.00–1.10 0.034 1.09 1.04–1.14 <0.001
LDL-C/HDL-C 1.12 1.02–1.23 0.017 1.20 1.10–1.31 <0.001
ApoB100/apoAI 2.30 1.51–3.51 <0.001 3.09 2.07–4.61 <0.001
OR odds ratio, 95 % CI 95 % confidence interval, TG/HDL-C triglyceride/high-density lipoprotein cholesterol, TC/HDL-C total cholesterol/high-density lipoprotein
cholesterol, LDL-C/HDL-C low-density lipoprotein cholesterol/high-density lipoprotein cholesterol, apoB100/apoAI apolipoprotein AI/apolipoprotein B100
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apoAI→ the tertile of the Gensini scores or the number
of stenotic vessels, age→HDL-C→ apoB100/apoAI→
the tertile of the Gensini scores or the number of sten-
otic vessels, male gender→HDL-C→ apoB100/
apoAI→ the tertile of the Gensini scores or the number
of stenotic vessels, BMI→HDL-C→ apoB100/apoAI→
the tertile of the Gensini scores or the number of sten-
otic vessels, LDL-C→ apoB100/apoAI→ the tertile of
the Gensini scores or the number of stenotic vessels,
BMI→ LDL-C→ apoB100/apoAI→ the tertile of the
Gensini scores or the number of stenotic vessels,
apoAI→ apoB100/apoAI→ the tertile of the Gensini
Table 4 Results of multivariate ordinal logistic regression of the lipoprotein ratios and the tertile of the Gensini scores or the
number of stenotic vessels
Variables The tertile of the Gensini scores The number of stenotic vessels
OR 95 % CI P OR 95 % CI P
TG/HDL-C
Model 1 1.02 0.98–1.08 0.339 1.05 1.00–1.10 0.033
Model 2 0.98 0.91–1.05 0.576 1.00 0.93–1.07 0.983
Model 3 a 0.98 0.91–1.05 0.536 1.04 0.90–1.21 0.600
LDL-C/HDL-C
Model 1 1.16 1.02–1.31 0.019 1.39 1.22–1.58 <0.001
Model 2 0.99 0.827–1.19 0.909 1.01 0.83–1.22 0.960
Model 3 b 1.13 0.77–1.66 0.533 0.87 0.57–1.31 0.499
TC/HDL-C
Model 1 1.07 1.01–1.14 0.030 1.13 1.06–1.21 <0.001
Model 2 0.97 0.89–1.72 0.485 0.99 0.91–1.08 0.888
Model 3 b 0.87 0.65–1.16 0.334 0.81 0.59–1.10 0.176
ApoB100/apoAI
Model 1 2.73 1.60–4.66 <0.001 4.79 2.80–8.20 <0.001
Model 2 3.18 1.30–7.76 0.011 2.55 1.04–6.28 0.041
Model 3 c 2.93 1.17–7.34 0.022 3.14 1.01–6.47 0.048
Model 1, adjusted for the non-lipid CHD risk factors including age, gender, weight, BMI, smoking, alcohol consumption, diabetes mellitus and hypertension;
Model 2, adjusted for the variables in Model 1 plus the individual lipid variables including TG, HDL-C, LDL-C, apoB100 and apoAI; Model 3 a, adjusted for the
variables in Model 2 plus the lipoprotein ratios including LDL-C/HDL-C and apoB100/apoAI; Model 3 b, adjusted for the variables in Model 2 plus the lipoprotein
ratios including TG/HDL-C and apoB100/apoAI; Model 3 c, adjusted for the variables in Model 2 plus the lipoprotein ratios including TG/HDL-C and LDL-C/HDL-C
OR odds ratio, 95 % CI 95 % confidence interval, TG/HDL-C triglyceride/high-density lipoprotein cholesterol, TC/HDL-C total cholesterol/high-density lipoprotein
cholesterol, LDL-C/HDL-C low-density lipoprotein cholesterol/high-density lipoprotein cholesterol, apoB100/apoAI apolipoprotein AI/apolipoprotein B100
Fig. 1 Significant regression paths among dependent (the tertile of the Gensini scores) and independent variables. *P ≤ 0.05, **P ≤ 0.01,
standardized regression coefficients (β) or odds ratios (OR) represented as one-way arrows
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scores or the number of stenotic vessels, male gender→
apoAI→ apoB100/apoAI→ the tertile of the Gensini
scores or the number of stenotic vessels, and apoB100→
apoB100/apoAI→ the tertile of the Gensini scores or
the number of stenotic vessels) through which apoB100/
apoAI mediated the indirect effects of the CHD risk fac-
tors on the severity of CHD.
Discussion
We have previously established a predictive role of lipo-
protein ratios for the occurrence of CHD [7]. We found
that the lipoprotein ratios were superior to individual
lipid parameters as predictors for CHD, and apoB100/
apoAI was the best one to predict the CHD risk. In the
present study, the associations between the lipoprotein
ratios and the severity of CHD were further investigated
and the results showed that the ratio of apoB100/apoAI,
but not the HDL-C related ratios (i.e. TG/HDL-C, TC/
HDL-C and LDL-C/HDL-C), was significantly and inde-
pendently associated with the severity of CHD. The stat-
istical power calculations revealed that there was ≥ 87 %
power to detect a significant association between the ra-
tio of apoB100/apoAI and the severity of CHD (α = 0.05)
with an effect size of ORs ≥ 2.30 in univariate and multi-
variate analyses. The design of our study is unique in
that both the Gensini scores and the number of stenotic
coronary branches were employed to evaluate the sever-
ity of CHD in one study.
To the best of our knowledge, this study is the first
one indicating that the apoB100/apoAI ratio is a
strong predictor for the severity of CHD in Chinese
Han people. The Han people are the largest ethnic
group in East Asia, constituting approximately 92 %
of the population of Mainland China, 98 % of the
population of Taiwan, and 74 % of the population of
Singapore. Previous studies have shown that high
apoB100/apoAI ratio is independently correlated with
the presence of angiographic CHD [7, 13, 17, 18]. In
the current study, we further revealed that this ratio
index is independently associated with the severity of
CHD. The apoB100/apoAI ratio increased orderly
with the severity of stenosis expressed by the tertile
of the Gensini scores (Table 1), but also with the
number of stenotic coronary branches (Table 2). In
univariate logistic regression, the apoB100/apoAI ratio
showed a strong relationship with the tertile of the
Gensini scores and the number of stenotic vessels
(Table 3), and this association was not appreciably al-
tered after adjusting for age, gender, weight, BMI,
smoking, alcohol consumption, diabetes mellitus,
hypertension, TG, LDL-C, HDL-C, TG/HDL-C and
LDL-C/HDL-C in the following multivariate logistic
regression (Table 4). Taken together, these results in-
dicate that the apoB100/apoAI ratio could be a strong
predictor for the severity of CHD.
In path analysis, we found that some conventional car-
diovascular risk factors such as male gender, BMI, HDL-
C, LDL-C, apoB100 and apoAI had indirect effects on
the severity of CHD, and apoB100/apoAI acted as a key
mediator in this process. Age and apoAI can directly
affect the severity of CHD, and they also had indirect ef-
fects on the severity of CHD through the mediation of
apoB100/apoAI. In addition, the results of the path ana-
lysis showed that smoking and diabetes had significant
effects on the severity of CHD independently of the ratio
of apoB100/apoAI and other lipid parameters.
Fig. 2 Significant regression paths among dependent (the number of stenotic vessels) and independent variables. *P ≤ 0.05, **P ≤ 0.01,
standardized regression coefficients (β) or odds ratios (OR) represented as one-way arrows
Song et al. Lipids in Health and Disease  (2015) 14:150 Page 6 of 9
It is theoretically reasonable that the ratio of apoB100/
apoAI is strongly associated with the severity of CHD.
Each particle of the atherogenic lipoproteins, such as
low-density lipoprotein, very low-density lipoprotein,
intermediate-density lipoprotein and lipoprotein(a), car-
ries one apoB100 molecule, so the concentrations of
plasma apoB100 can reflect the total of proatherogenic
potentials. On the other hand, apoAI is the major apoli-
poprotein component of antiatherogenic lipoprotein, i.e.
high-density lipoprotein, the serum content of apoAI
represents the total of antiatherogenic potentials. Thus,
the apoB100/apoAI ratio could comprehensively reflect
the balance between the atherogenic and antiatherogenic
potentials in one individual. The higher is the apoB100/
apoAI ratio, the more are the atherogenic potentials, or
the less are the antiatherogenic potentials, or both.
The ratio of TG/HDL-C was found to be associated
with the number of stenotic vessels, but not the tertile
of the Gensini scores by univariate logistic regression
(Table 3). In multivariate logistic regression, TG/HDL-C
was significantly associated with the number of stenotic
vessels after adjusting for the non-lipid cardiovascular
risk factors including age, gender, weight, BMI, smoking,
alcohol consumption, diabetes mellitus and hypertension
in model 1. However, it became insignificant when the
individual lipid parameters (i.e. TG, LDL-C, HDL-C,
apoB100 and apoAI) were added to the model (model
2), which indicates that the predictive power of TG/
HDL-C to the number of stenotic vessels can be re-
placed by the individual lipid parameters. Our findings
are consistent with the results of a hospital-based study
[9], in which Yang D et al. demonstrated that the TG/
HDL-C ratio was not associated with the Gensini scores
in Chinese CHD patients. However, in another case–
control study which was also involved in Chinese CHD
patients, Yunke Z et al. [11] reported that the TG/HDL-
C ratio can predict the severity of CHD and the incident
of new-onset heart failure among in-hospital CHD pa-
tients. In Brazilians, da Luz PL et al. [12] also demon-
strated that the TG/HDL-C ratio was associated with the
severity of CHD. The association between the TG/HDL-
C ratio and the severity of CHD needs to be further
studied.
The ratios of TC/HDL-C and LDL-C/HDL-C were as-
sociated with both the tertile of the Gensini scores and
the number of stenotic vessels in univariate logistic re-
gression analyses (Table 3). In the following multivariate
logistic regression, the significant associations persisted
when controlled for the non-lipid variables in model 1.
However, the associations were completely abolished for
both TC/HDL-C and LDL-C/HDL-C when individual
lipid variables were added in model 2. The associations
between the ratios of TC/HDL-C and LDL-C/HDL-C
and the severity of CHD could be mediated by the
individual lipid parameters. Contrary to our findings, the
significant associations between the ratios of TC/HDL-C
and LDL-C/HDL-C and the severity of CHD were re-
ported by other investigators. Yang D et al. [9] reported
a significant and positive correlation between the ratios
of TC/HDL-C and LDL/HDL-C and the Gensini scores
in Chinese patients. Lippi U et al. [8] demonstrated that
the TC/HDL-C and LDL/HDL-C ratios, but not the
plasma levels of TG, TC, HDL-C and LDL-C are statisti-
cally related to the mild severity of CHD. In a recent
cross-sectional association study [10], Platt DE et al. re-
ported that the TC/HDL-C ratio is a strong biological
marker for CHD occurrence and severity, and the TC/
HDL-C ratio ≥ 4 significantly predicts ≥ 50 % stenosis in
all vessels. However, apoB100 and apoAI were not
enrolled into the regression models in all the above-
mentioned studies [8–10], so it is not clear that the asso-
ciations between the TC/HDL-C and LDL/HDL-C ratios
and the severity of CHD were independent of apoB100
and apoAI.
Our study has several limitations. First, the present
study was not designed to examine all the risk factors
associated with the severity of CHD. Rather, the specific
goal was to examine whether the lipoprotein ratios were
associated with the severity of CHD. Second, our study
mainly focused on the CHD patients whose lesions of
coronary artery were 50 % or more in at least one major
branch according to the diagnostic criteria. Those with
mild coronary stenosis (less than 50 %) were not en-
rolled in this study although the lipoprotein ratios might
also be associated with mild stenosis.
Conclusions
In conclusion, the results of our study suggest that the
ratio of apoB100/apoAI could be a powerful predictor
for the severity of CHD.
Patients and methods
CHD patients
Details of this study have been published previously [7].
Briefly, a total of 792 consecutive unrelated atheroscler-
otic CHD patients who underwent coronary angiography
at the Affiliated Hospital of North Sichuan Medical Col-
lege (Nanchong, China) were enrolled in the study be-
tween May 2011 and April 2015. Patients taking lipid
lowering drugs or the drugs that might affect the glucose
or lipid metabolism were excluded from the study. In
order to enlarge the sample size, the patients who took
the drugs which were thought not to affect plasma lipid
levels were still enrolled in the study. Patients with renal
or hepatic dysfunction, significant valvular disease, myo-
carditis, and malignant disease were excluded from the
study. All the subjects were Chinese Han people. The te-
nets of the Declaration of Helsinki were adhered to in
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all procedures in the study. The study protocol was ap-
proved by the ethics committee of North Sichuan Med-
ical College. Written consent was provided by all the
participants or their guardians prior to their participa-
tion in the study.
Coronary angiography
The Gensini scoring system and the number of stenotic
coronary branches were used to assess the severity of
CHD. Patients were stratified into three groups based on
the tertile of the Gensini scores or the number of sten-
otic coronary branches. Coronary angiograms were eval-
uated by experienced cardiologists who were not aware
of the patients’ biochemical status. Standard coronary
angiography with at least two views of the right coronary
artery and four views of the left coronary system were
performed using the Judkins technique by Allura Xper
FD20 (Philips Medical Systems Nederland B.V.
Netherlands). Atherosclerotic CHD was diagnosed in pa-
tients who had angiographic evidence of stenosis greater
than 50 % in at least one major coronary artery. Those
with normal coronary arteries or minimal stenosis (less
than 50 %) in any of the major coronary arteries were
excluded from the study.
Diagnostic criteria
Body mass index (BMI) was calculated by dividing
weight by height squared (kg/m2). Smoking was defined
as regular cigarette smoking. Hypertension was defined
as the measurement of systolic/diastolic blood pressure
higher than 140/90 mmHg or active use of antihyperten-
sive drugs. Diabetes mellitus was defined as the fasting
glucose levels above 126 mg/dL or active use of antidia-
betic drugs or insulin.
Biochemical measurement
Fasting blood samples were taken on the first morning
of the in-hospital day when lipid-lowering drugs were
not yet used. Samples were immediately transported to
the Department of Clinical Laboratory of the Affiliated
Hospital of North Sichuan Medical College for measure-
ment of plasma lipids. TG, TC, LDL-C and HDL-C were
measured directly by enzymatic methods. ApoB100 and
apoAI were measured by immunoturbidimetric assays.
All the measurements were carried out using an auto-
matic clinical chemistry analyzer (Beckman Coulter
AU5800, USA). Lipoprotein ratios were calculated.
Statistical analysis
Data are presented as mean ± standard deviation (SD)
unless otherwise stated. Continuous variables were
tested for normality; otherwise, log transformation was
applied. All statistical analyses were carried out by using
SPSS version 13.0 (SPSS Inc., Chicago, IL, USA). The
differences among the three groups categorized by the
tertile of the Gensini scores or the number of stenotic
vessels were calculated by Chi-square test for categorical
variables, and one-way ANOVA analysis for continuous
variables. Univariate and multivariate ordinal logistic re-
gression analyses were employed to determine the asso-
ciations between the lipoprotein ratios and the severity
of atherosclerotic CHD. The results of logistic regression
analysis were expressed as the odds ratio (OR) with 95 %
confidence interval (95 % CI). In the multivariate regres-
sion, collinearity among the independent variables was
diagnosed by examining variance inflation factor (VIF)
and tolerance. Path analysis was used to examine the
causal relationships among the non-lipid cardiovascular
risk factors, individual lipid variables, lipoprotein ratios
and the severity of CHD. Power calculations were per-
formed using the PASS 14 program based on Hsieh’s
method [19]. All P-values are two-tailed and differences
were considered significant if P ≤ 0.05.
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